Immunoregulatory Macrophages Modify Local Pulmonary Immunity and Ameliorate Hypoxic Pulmonary Hypertension.
adoptive transfer
hypoxia
macrophage activation
pulmonary arterial hypertension
vascular remodeling
Journal
Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803
Informations de publication
Date de publication:
10 Oct 2024
10 Oct 2024
Historique:
medline:
10
10
2024
pubmed:
10
10
2024
entrez:
10
10
2024
Statut:
aheadofprint
Résumé
Macrophages play a significant role in the onset and progression of vascular disease in pulmonary hypertension, and cell-based immunotherapies aimed at treating vascular remodeling are lacking. To evaluate the effect of pulmonary administration of macrophages modified to have an anti-inflammatory/proresolving phenotype in attenuating early pulmonary inflammation and progression of experimentally induced pulmonary hypertension. Mouse bone marrow-derived macrophages were polarized in vitro to a regulatory (M2 M2 Adoptive transfer of M2
Sections du résumé
BACKGROUND
UNASSIGNED
Macrophages play a significant role in the onset and progression of vascular disease in pulmonary hypertension, and cell-based immunotherapies aimed at treating vascular remodeling are lacking. To evaluate the effect of pulmonary administration of macrophages modified to have an anti-inflammatory/proresolving phenotype in attenuating early pulmonary inflammation and progression of experimentally induced pulmonary hypertension.
METHODS
UNASSIGNED
Mouse bone marrow-derived macrophages were polarized in vitro to a regulatory (M2
RESULTS
UNASSIGNED
M2
CONCLUSIONS
UNASSIGNED
Adoptive transfer of M2
Identifiants
pubmed: 39387119
doi: 10.1161/ATVBAHA.124.321264
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM